Pancreatitis, Chronic
Gastroenterology
0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
GuerbetFrance - Villepinte
1 programPancreatic Duct Evaluation in Autoimmune Pancreatitis: MR PancreatographyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
GuerbetPancreatic Duct Evaluation in Autoimmune Pancreatitis: MR Pancreatography
Clinical Trials (1)
Total enrollment: 30 patients across 1 trials
Pancreatic Duct Evaluation in Autoimmune Pancreatitis: MR Pancreatography
Start: Jan 2013Est. completion: Mar 201530 patients
N/ACompleted
Related Jobs in Gastroenterology
Specialty Representative, Gastroenterology – Minneapolis, Minnesota
AbbVie
Remote
11h ago
Head of Drug Product Development
Ironwood Pharmaceuticals
Boston, Massachusetts, United States
12h ago
$246K - $287K/yr
Regulatory Affairs Associate
Ferring Pharmaceuticals
Istanbul, Turkey
Yesterday
Key Account Director, Diagnostics and Research
Tempus
Remote
Yesterday
$150K - $200K/yr
QA Operation Platform Lead
Johnson & Johnson
Yokneam, Haifa District, Israel
Yesterday
Value Architecture & Engineering Lead
Johnson & Johnson
Titusville, New Jersey, United States of America
Yesterday
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space